Biohaven Pharmaceutical Holding Company Ltd (NYSE:BHVN)
| 43.80 Delayed Data As of Feb 25 |  -0.69 / -1.55%Today’s Change | 36.69 Today|||52-Week Range 67.86 | -19.54% Year-to-Date |
Latest BHVN News | Press Releases
| Should Investors Buy Biohaven's Stock Now? Feb 13 / MotleyFool.com - Paid Partner Content |
Today’s Trading
| Previous close | 44.49 |
| Today’s open | 44.88 |
| Day’s range | 42.90 - 45.33 |
| Volume | 784,629 |
| Average volume (3 months) | 796,564 |
| Market cap | $2.6B |
Data as of 6:30pm ET, 02/25/2020
Growth & Valuation
| Earnings growth (last year) | -22.98% |
| Earnings growth (this year) | -60.15% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | -- |
| P/E ratio | NM |
| Price/Sales | -- |
| Price/Book | 13.25 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| ARNAArena Pharmaceutical... | -1.48 | -3.01% |
| APLSApellis Pharmaceutic... | -1.06 | -2.98% |
| FOLDAmicus Therapeutics ... | -0.59 | -5.67% |
| ---- |
Data as of 4:00pm ET, 02/25/2020
Financials
| Next reporting date | March 4, 2020 |
| EPS forecast (this quarter) | -$1.87 |
| Annual revenue (last year) | $0.00 |
| Annual profit (last year) | -$240.9M |
| Net profit margin | -- |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters New Haven, Connecticut |
Forecasts
